Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
|---|---|---|---|---|---|
| C0003504 | Aortic Valve Insufficiency | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
| C0017665 | Membranous glomerulonephritis | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0086445 | Idiopathic Membranous Glomerulonephritis | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0678222 | Breast Carcinoma | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C1306459 | Primary malignant neoplasm | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0024138 | Lupus Erythematosus, Discoid | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0006826 | Malignant Neoplasms | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0024141 | Lupus Erythematosus, Systemic | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0376358 | Malignant neoplasm of prostate | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0268731 | Renal glomerular disease | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C1332977 | Childhood Leukemia | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0027726 | Nephrotic Syndrome | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0038586 | Substance Use Disorders | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0024143 | Lupus Nephritis | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0027651 | Neoplasms | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0017658 | Glomerulonephritis | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0236969 | Substance-Related Disorders | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0085669 | Acute leukemia | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0027707 | Nephritis, Interstitial | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0022658 | Kidney Diseases | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0549473 | Thyroid carcinoma | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0013222 | Drug Use Disorders | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0013146 | Drug abuse | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0004364 | Autoimmune Diseases | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
| C0007134 | Renal Cell Carcinoma | PLA2R1 | 22925 | phospholipase A2 receptor 1 | Q13018 |
